IP Library Patent Application 12157284
Patent Application
App. No. 12/157,284

Methods for modulating neuronal cell death

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/157,284
Abstract

The invention provides methods of inhibiting Aβ-induced neuronal cell death. The invention further provides methods of providing neuroprotection to a subject and methods of treating a disease state characterized by Aβ-induced neuronal cell death in a subject. Methods of inhibiting p75 receptor mediated neuronal cell death, as well as methods of treating a disease state in a subject characterized by p75 receptor mediated neuronal cell death are provided.

Claims (6)

1 . A method for providing neuroprotection to a subject susceptible to or having a condition characterized by neurodegeneration, neuronal cell toxicity, neuronal cell death, decreased neuronal cell communication or senility comprising administering 3-amino-1-propanesulfonic acid or an acceptable salt thereof to the subject.

2 . The method according to claim 1 , comprising administering 3-amino-1-propanesulfonic acid.

3 . The method according to claim 1 , comprising administering 3-amino-1-propanesulfonic acid, sodium salt.

4 . The method according to claim 1 , wherein said 3-amino-1-propanesulfonic acid or acceptable salt thereof is formulated for oral administration.

5 . The method of claim 1 , wherein said condition is further characterized by the presence of neurotoxic Aβ peptides or proteins.

6 . The method of claim 5 , wherein the neurotoxic Aβ peptides or proteins is soluble Aβ.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2012
From: BELLUS HEALTH INC.
To: BHI LIMITED PARTNERSHIP
Reel/Frame 028758/0113 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2011
From: BELLUS HEALTH (INTERNATIONAL) LIMITED
To: BELLUS HEALTH INC.
Reel/Frame 026399/0185 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE RECEIVING PARTY (BELLUS HEALTH (INTERNATIONAL) LIMITED) PREVIOUSLY RECORDED ON REEL 022087 FRAME 0744. ASSIGNOR(S) HEREBY CONFIRMS THE ADDRESS: PSE-PARC SCIENTIFIQUE SUR LE SITE DE L'ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE, ECUBLENS, CH-1015 LAUSANNE SWITZERLAND. Recorded Mar 11, 2009
From: NEUROCHEM (INTERNATIONAL) LIMITED
To: BELLUS HEALTH (INTERNATIONAL) LIMITED
Reel/Frame 022379/0469 →
CHANGE OF NAME Recorded Jan 12, 2009
From: NEUROCHEM (INTERNATIONAL) LIMITED
To: BELLUS HEALTH (INTERNATIONAL) LIMITED
Reel/Frame 022087/0744 →